Stella Diagnostics Inc (SLDX)

[doone]

I have seen it before with other OTC's. What happens generally, is that get caught up with giving out too much information (aka transparency), then they cannot keep up with all the claims they make. Ultimately their counsel says you better stop. This will happen here, guaranteed. Trouble is once shareholders have gotten used to all that great "transparency", and it ceases, party is over.

There was a lot of excitement and everyone went nuts over the CC's—and I suspect other penny stock CEO's will be copying that immediately as part of THEIR tactics because it was a successful ploy.